Skip to main content
Home Home

User account menu

Log in

Main navigation

  • Home
  • Topics
    • Antimicrobials
    • Asthma
    • Biological medicines
    • COVID-19 medicines
    • Cardiovascular disease
    • Equity
    • Focus medicines
    • Gout
    • Menopause
    • Type 2 diabetes
    • Youth mental health
  • Resources
    • All education/search
    • Brand changes
    • Clinical articles
    • HAH Bulletins
    • Podcasts
    • Recorded webinars
    • Reflect & audit activities
    • Resource hubs
    • Videos
  • EPiC dashboard
    • Go to EPiC
    • Join EPiC
    • EPiC FAQ
    • EPiC Demo
    • About EPiC
    • Book EPiC training
  • News
    • Events
    • That's Interesting
    • From The Team
    • Coming Soon

Education

  1. Home
  2. Search

The hub for all your learning resources.

Here you will find all our clinical education resources from articles to recorded webinars, all supporting equitable access to funded medicines.

Image of a molecular structure

Introduction to biological medicines

4 minutes to Read + 15 minutes to Explore

Biological medicines are already used in Aotearoa New Zealand and with more being developed internationally, it’s important that health professionals feel comfortable prescribing, dispensing, and supporting patients to use them.

We’ve highlighted five key aspects of these medicines in an article and a series of short animated videos. After completing each section, you can take a short quiz to test your learning.

Contributor
He Ako Hiringa
11 August 2021
  • Biological medicines
  • Videos
  • Clinical article
ECG

Switching blood pressure medications – it’s time to break the cilazapril habit

3 minutes to Read

Last year, cilazapril with hydrochlorothiazide was discontinued, and now cilazapril alone is no longer funded for new patients. Consultant cardiologist Chris Ellis discusses what to do when patients with hypertension run out of their supply of these medications

Contributor
Chris Ellis
2 August 2021
  • CVD
  • Clinical article
Bulletin #5

Cilazapril unplugged – what alternatives?

1 minute to Read

Prescribers wanting to block angiotensin II effects can consider the remaining funded ACE inhibitors or angiotensin II receptor blockers. ACE inhibitors and ARBs are similarly effective for hypertension, chronic renal disease and diabetic nephropathy, but ARBs are better tolerated. ACE inhibitors are preferred over ARBs first-line for heart failure and post myocardial infarction.

Read the HAH Bulletin to find out more.

Contributor
He Ako Hiringa
19 July 2021
  • HAH Bulletins
  • CVD
The 5 As - availability, accessibility, affordability and appropriateness

The five drivers of medicine access equity

1 minute to Read

Pharmac has identified five key drivers of medicine access equity in New Zealand. Read on to learn about the drivers and how you can implement them in your place of work. 

13 July 2021
  • Equity
person leaping across a void

Starting injectable medicine: How to prepare your T2D patients

7 minutes to Read

Dulaglutide, a once-weekly injectable medicine, will soon be available for second-line treatment of type 2 diabetes. As most people with type 2 diabetes will require an injectable therapy at some stage, it is important to build acceptability early in the patient journey.

Contributor
Louise Roche Farmer
29 June 2021
  • Diabetes
  • Clinical article
Bulletin #4

Being culturally competent is not enough

1 minute to Read + 2 minutes to Delve

Cultural competence vs safety – related, but different

A culturally competent practitioner knows about the beliefs and behaviours of patients from different cultures, and has the skill to apply this knowledge to healthcare delivery.

Read the HAH Bulletin to find out more.

Contributor
He Ako Hiringa
21 June 2021
  • HAH Bulletins
  • Equity
HealthPathways

Updated diabetes HealthPathways bravely paved with equity

6 minutes to Read

Careful writing and editing, and an equity lens, have been instrumental in updating the type 2 diabetes HealthPathways, helping to reduce unnecessary variation in treatment plans and outcomes.

 

Contributor
Lisa Dick
3 June 2021
  • Equity
Bulletin #3

Improving medicine adherence to optimise outcomes

1 minute to Read + 2 minutes to Delve

Compliance, adherence, concordance – confused?

Whatever terminology is used, studies show that differences in health literacy, medicines access, attitudes to health and prescriber perceptions, may contribute to sub-optimal use of medicines and poor health outcomes.

Read the HAH Bulletin to find out about strategies to improve medicine access and supply.

Contributor
He Ako Hiringa
24 May 2021
  • HAH Bulletins
  • Equity
Image of an older Māori man in a pharmacy

Medicines and older Māori

2 minutes to Read + 43 minutes to Explore

Focusing on the experiences of older Māori in primary care, this course comprises four short videos, an independent reflection, downloadable posters and additional resources.

The course is endorsed by RNZCGP and CNA(NZ) and meets PCNZ recertification requirements. Reflection templates are included for you to complete.

Contributor
Dr Jo Hikaka
18 May 2021
  • Equity
  • Videos
  • Reflect & audit activities
HAH Applied

Targeting optimal HbA1c level in type 2 diabetes using appropriate blood glucose lowering medicine

This Quality Improvement Activity enables you to review the glycaemic management of your type 2 diabetes patients and identify those who may benefit from initiation or intensification of blood glucose lowering medicines.

Good glycaemic control has a clear benefit on microvascular outcomes and if started early enough, on long-term macrovascular outcomes of coronary artery disease, stroke and peripheral vascular disease.

Contributor
He Ako Hiringa
3 May 2021
  • Diabetes
  • Reflect & audit activities
  • Equity
New way, this way, another way, that way

Supporting patients to take the new diabetes meds: What you need to know

11 minutes to Read

Diabetes clinical nurse specialist Lisa Sparks discusses the place of empagliflozin and dulaglutide in treatment of type 2 diabetes, with emphasis on potential side effects, sick-day management and improving patient adherence.

Contributor
Lisa Sparks
30 April 2021
  • Diabetes
  • Clinical article
Meeting the needs of Māori

Meeting the needs of Māori

20 minutes to Read

Māori attitudes to healthcare today are deeply rooted in New Zealand history. In this article, Deborah Bassett-Clarke discusses some reasons why the current model of pharmacy practice does not always meet the needs of Māori and may actually cause health inequities. Understanding these factors is an important first step to improving outcomes for Māori.

Contributor
Deborah Bassett-Clarke
30 April 2021
  • Equity
  • Clinical article

Pagination

  • « First First page
  • ‹ Previous Previous page
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • Next › Next page
  • Last » Last page
Home Home

Contact Us

PO Box 31905, Milford Auckland NZ, 0741

Support

09 488 4286

admin@akohiringa.co.nz

(9-5pm Mon-Fri)

Contact us

About us

Terms & Policies

  • Conditions for Use
  • Privacy Policy

Supported by

Pharmac

© Matui Limited. All rights reserved.

Developed by Matui Limited and brought to life by Communica.